Lysophosphatidic acid protects human mesenchymal stromal cells from differentiation-dependent vulnerability to apoptosis

Tissue Engineering - Part A

Volumn 20, Issue 7-8, 2014, Pages 1156-1164

  Binder, Bernard Y K ^a   Genetos, Damian C ^b   Leach, J Kent ^a,c  

^a University of California Davis   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; DRUG PRODUCTS; ENDOTHELIAL CELLS; PHOSPHOLIPIDS;

BIOLUMINESCENCE IMAGING; LYSOPHOSPHATIDIC ACID; MESENCHYMAL STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; OSTEOGENIC SUPPLEMENTS; PLATELET-DERIVED GROWTH FACTORS; PLEIOTROPIC EFFECTS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

CELL ENGINEERING;

ALGINIC ACID; DEXAMETHASONE; LYSOPHOSPHATIDIC ACID; VASCULOTROPIN; CULTURE MEDIUM; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHOLIPID; VASCULOTROPIN A;

APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROTECTION; CELL SURVIVAL; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CELL HYPOXIA; CELL PROLIFERATION; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; METABOLISM; MOUSE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; CYTOPROTECTION; HUMANS; LYSOPHOSPHOLIPIDS; MESENCHYMAL STROMAL CELLS; MICE; OSTEOGENESIS; RECEPTORS, LYSOPHOSPHATIDIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84898484540     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0487     Document Type: Article

References (48)

1. Caplan, A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213, 341, 2007
2. Caplan, A.I. New era of cell-based orthopedic therapies. Tissue Eng Part B Rev 15, 195, 2009
3. Peter, S.J., Liang, C.R., Kim, D.J., Widmer, M.S., and Mikos, A.G. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-Ascorbic acid. J Cell Biochem 71, 55, 1998
4. Hoch, A.I., Binder, B.Y., Genetos, D.C., and Leach, J.K. Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PloS One 7, e35579, 2012
5. Xu, H.H., Zhao, L., and Weir, M.D. Stem cell-calcium phosphate constructs for bone engineering. J Dental Res 89, 1482, 2010
6. Kang, S.W., Lee, J.S., Park, M.S., Park, J.H., and Kim, B.S. Enhancement of in vivo bone regeneration efficacy of human mesenchymal stem cells. J Microbiol Biotechnol 18, 975, 2008
7. Potier, E., Ferreira, E., Meunier, A., Sedel, L., Logeart-Avramoglou, D., and Petite, H. Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng 13, 1325, 2007
8. Das, R., Jahr, H., van Osch, G.J., and Farrell, E. The role of hypoxia in bone marrow-derived mesenchymal stem cells: Considerations for regenerative medicine approaches. Tissue Eng Part B Rev 16, 159, 2010
9. Chen, J., Baydoun, A.R., Xu, R., Deng, L., Liu, X., Zhu, W., et al. Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis. Stem Cells 26, 135, 2008
10. Li, Z., Wei, H., Liu, X., Hu, S., Cong, X., and Chen, X. LPA rescues ER stress-Associated apoptosis in hypoxia and serum deprivation-stimulated mesenchymal stem cells. J Cell Biochem 111, 811, 2010
11. Sun, Y., Nam, J.S., Han, D.H., Kim, N.H., Choi, H.K., Lee, J.K., et al. Lysophosphatidic acid induces upregulation of Mcl-1 and protects apoptosis in a PTX-dependent manner in H19-7 cells. Cell Signal 22, 484, 2010.
12. Liu, X.B., Jiang, J.,Gui, C.,Hu, X.Y.,Xiang,M.X., andWang, J.A. Angiopoietin-1 protects mesenchymal stem cells against serum deprivation and hypoxia-induced apoptosis through the PI3K/Akt pathway. Acta Pharmacol Sin 29, 815, 2008
13. Moolenaar, W.H. Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 270, 12949, 1995
14. Noguchi, K., Herr, D., Mutoh, T., and Chun, J. Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 9, 15, 2009
15. Tigyi, G. Aiming drug discovery at lysophosphatidic acid targets. Br J Pharmacol 161, 241, 2010
16. Yanagida, K., and Ishii, S. Non-Edg family LPA receptors: The cutting edge of LPA research. J Biochem 150, 223, 2011
17. Kleger, A., Liebau, S., Lin, Q., von Wichert, G., and Seufferlein, T. The impact of bioactive lipids on cardiovascular development. Stem Cells Int 2011, 916180, 2011
18. Teo, S.T., Yung, Y.C., Herr, D.R., and Chun, J. Lysophosphatidic acid in vascular development and disease. IUBMB Life 61, 791, 2009
19. Liu, X., Hou, J., Shi, L., Chen, J., Sang, J., Hu, S., et al. Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo. Stem Cells Dev 18, 947, 2009
20. R&D Systems. Annual Catalog. 2012. www.rndsystems .com/products.aspx 21. Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439, 2004
21. Viateau, V., Guillemin, G., Bousson, V., Oudina, K., Hannouche, D., Sedel, L., et al. Long-bone critical-size defects treated with tissue-engineered grafts: A study on sheep. J Orthop Res 25, 741, 2007
22. Schmitt, A., van Griensven, M., Imhoff, A.B., and Buchmann, S. Application of stem cells in orthopedics. Stem Cells Int 2012, 394962, 2012
23. Rothenberg, A.R., Ouyang, L., and Elisseeff, J.H. Mesenchymal stem cell stimulation of tissue growth depends on differentiation state. Stem Cells Dev 20, 405, 2011
24. Tarantal, A.F., Lee, C.C., Batchelder, C.A., Christensen, J.E., Prater, D., and Cherry, S.R. Radiolabeling and in vivo imaging of transplanted renal lineages differentiated from human embryonic stem cells in fetal rhesus monkeys. Mol Imaging Biol 14, 197, 2012
25. He, J., Decaris, M.L., and Leach, J.K. Bioceramic-mediated trophic factor secretion by mesenchymal stem cells enhances in vitro endothelial cell persistence and in vivo angiogenesis. Tissue Eng Part A 18, 1520, 2012
26. Decaris, M.L., Lee, C.I., Yoder, M.C., Tarantal, A.F., and Leach, J.K. Influence of the oxygen microenvironment on the proangiogenic potential of human endothelial colony forming cells. Angiogenesis 12, 303, 2009
27. Davis, H.E., Rao, R.R., He, J., and Leach, J.K. Biomimetic scaffolds fabricated from apatite-coated polymer microspheres. J Biomed Mater Res Part A 90, 1021, 2009
28. Decaris, M.L., and Leach, J.K. Design of experiments approach to engineer cell-secreted matrices for directing osteogenic differentiation. Ann Biomed Eng 39, 1174, 2011
29. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402, 2001
30. Sun, Q., Silva, E.A., Wang, A., Fritton, J.C., Mooney, D.J., Schaffler, M.B., et al. Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis. Pharm Res 27, 264, 2010
31. Silva, E.A., Kim, E.S., Kong, H.J., and Mooney, D.J. Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A 105, 14347, 2008
32. Davis, H.E., Binder, B.Y., Schaecher, P., Yakoobinsky, D.D., Bhat, A., and Leach, J.K. Enhancing osteoconductivity of fibrin gels with apatite-coated polymer microspheres. Tissue Eng Part A 19, 1773, 2013
33. Caplan, A.I., and Dennis, J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98, 1076, 2006
34. Liu, Y.B., Kharode, Y., Bodine, P.V., Yaworsky, P.J., Robinson, J.A., and Billiard, J. LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4. J Cell Biochem 109, 794, 2010
35. Elmore, S. Apoptosis: A review of programmed cell death. Toxicol Pathol 35, 495, 2007
36. Nicholson, D.W., and Thornberry, N.A. Caspases: Killer proteases. Trends Biochem Sci 22, 299, 1997
37. Song, I.H., Caplan, A.I., and Dennis, J.E. Dexamethasone inhibition of confluence-induced apoptosis in human mesenchymal stem cells. J Orthop Res 27, 216, 2009
38. Hung, S.C., Pochampally, R.R., Hsu, S.C., Sanchez, C., Chen, S.C., Spees, J., et al. Short-Term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PloS One 2, e416, 2007
39. Burlacu, A., Grigorescu, G., Rosca, A.M., Preda, M.B., and Simionescu, M. Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro. Stem Cells Dev 22, 643, 2012
40. Deveza, L., Choi, J., Imanbayev, G., and Yang, F. Paracrine release from nonviral engineered adipose-derived stem cells promotes endothelial cell survival and migration in vitro. Stem Cells Dev 22, 483, 2012
41. Dai, Y., Xu, M., Wang, Y., Pasha, Z., Li, T., and Ashraf, M. HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 42, 1036, 2007
42. Ma, Y., Liu, W., Wang, Y., Chao, X., Qu, Y., Wang, K., et al. VEGF protects rat cortical neurons from mechanical trauma injury induced apoptosis via the MEK/ERK pathway. Brain Res Bull 86, 441, 2011
43. Fierro, F.A., Kalomoiris, S., Sondergaard, C.S., and Nolta, J.A. Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells 29, 1727, 2011
44. He, J., Genetos, D.C., Yellowley, C.E., and Leach, J.K. Oxygen tension differentially influences osteogenic differentiation of human adipose stem cells in 2D and 3D cultures. J Cell Biochem 110, 87, 2010
45. Liu, L., Yu, Q., Lin, J., Lai, X., Cao, W., Du, K., et al. Hypoxia-inducible factor-1alpha is essential for hypoxiainduced mesenchymal stem cell mobilization into the peripheral blood. Stem Cells Dev 20, 1961, 2011
46. An, S.S., Jin, H.L., Kim, K.N., Kim, D.S., Cho, J., Liu, M.L., et al. Neuroprotective effect of combined hypoxiainduced VEGF and bone marrow-derived mesenchymal stem cell treatment. Child's Nerv Syst 26, 323, 2010
47. Davis, H.E., and Leach, J.K. Designing bioactive delivery systems for tissue regeneration. Ann Biomed Eng 39, 1, 2011
48. Ren, B., Hale, J., Srikanthan, S., and Silverstein, R.L. Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway. Blood 117, 6036, 2011.